These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 31962380)

  • 21. Hsa_circ_0000515 is a novel circular RNA implicated in the development of breast cancer through its regulation of the microRNA-296-5p/CXCL10 axis.
    Cai F; Fu W; Tang L; Tang J; Sun J; Fu G; Ye G
    FEBS J; 2021 Feb; 288(3):861-883. PubMed ID: 32446265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis.
    Sun J; Pan S; Cui H; Li H
    Curr Cancer Drug Targets; 2020; 20(6):461-470. PubMed ID: 32271695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ_0029803 serves as the sponge of miR-216b-5p to promote the progression of colorectal cancer by regulating SKIL expression.
    Huang L; Zhu L; Pan S; Xu J; Xie M; Wang W; Xia G
    World J Surg Oncol; 2021 Sep; 19(1):268. PubMed ID: 34479589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
    Xu S; Luo W; Li M; Li Q; Hong W; Gao Y; Yang J; Song H; Chen L; Yang Y; Yang C
    Clin Breast Cancer; 2023 Jan; 23(1):71-83. PubMed ID: 36289041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z; Yin J; Peng G; Long X
    Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis.
    Jiang J; Lin H; Shi S; Hong Y; Bai X; Cao X
    Thorac Cancer; 2020 Nov; 11(11):3181-3192. PubMed ID: 33000910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.
    Zhao Y; Ma X; Shi W
    Mamm Genome; 2021 Dec; 32(6):517-529. PubMed ID: 34632534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircRNA RNF10 inhibits tumorigenicity by targeting miR-942-5p/GOLIM4 axis in breast cancer.
    Kan B; Yan G; Shao Y; Zhang Z; Xue H
    Environ Mol Mutagen; 2022 Aug; 63(7):362-372. PubMed ID: 36054164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway.
    Xu Y; Yao Y; Leng K; Ji D; Qu L; Liu Y; Cui Y
    Cell Physiol Biochem; 2018; 51(4):1710-1722. PubMed ID: 30504704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ-POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR-876-5p/FYN axis.
    Chu A; Sun C; Liu Z; Liu S; Li M; Song R; Gan L; Wang Y; Fan R
    Thorac Cancer; 2024 May; 15(13):1082-1094. PubMed ID: 38553795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
    Jin Y; Wang H
    J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2.
    Chen Y; Li S; Wei Y; Xu Z; Wu X
    Bosn J Basic Med Sci; 2021 Oct; 21(5):555-568. PubMed ID: 33714261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of circular RNA circ-FARSA restricts colorectal cancer cell growth through regulation of miR-330-5p/LASP1 axis.
    Lu C; Fu L; Qian X; Dou L; Cang S
    Arch Biochem Biophys; 2020 Aug; 689():108434. PubMed ID: 32473899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.